ALX ONCOLOGY HOLDINGS INC (ALXO)
Pharmaceutical Preparations
Latest Price
$1.93
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.13
P/B Ratio
1.70
Institutional Ownership
75.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 13.01M | $26.0M | 9.41% | -- | 2026-06-30 |
| venBio Partners LLC | 12.88M | $26.0M | 9.32% | -- | 2026-06-30 |
| BlackRock, Inc. | 7.40M | $15.0M | 5.35% | +6.95M | 2026-06-30 |
| Redmile Group, LLC | 7.39M | $15.0M | 5.35% | -571.7K | 2026-06-30 |
| Blackstone Inc. | 6.59M | $13.0M | 4.77% | +767.0K | 2026-06-30 |
| Driehaus Capital Management LLC | 6.03M | $12.0M | 4.36% | +290.6K | 2026-06-30 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 5.74M | $11.0M | 4.16% | -- | 2026-06-30 |
| TCG Crossover Management, LLC | 5.66M | $11.0M | 4.09% | -7.36M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.97M | $10.0M | 3.60% | +793.7K | 2026-06-30 |
| Vivo Capital, LLC | 3.18M | $6.0M | 2.30% | -- | 2026-06-30 |